Advisor Group Holdings, Inc. Pharma Cyte Biotech, Inc. Transaction History
Advisor Group Holdings, Inc.
- $43.4 Billion
- Q1 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,767 shares of PMCB stock, worth $3,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,767
Previous 1,758
0.51%
Holding current value
$3,640
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PMCB
# of Institutions
32Shares Held
1.07MCall Options Held
5.4KPut Options Held
400-
K2 Principal Fund, L.P. Toronto, A6328KShares$674,6560.27% of portfolio
-
Geode Capital Management, LLC Boston, MA200KShares$412,5780.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA175KShares$359,6800.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$189,6997.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$170,4170.12% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $42.7M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...